Tarlatamab improves brain metastases control and survival compared to chemo in SCLC

Mezigdomide plus carfilzomib and dexamethasone delays disease progression in R/R multiple myeloma

Mobile app-based symptom monitoring helps maintain quality of life in advanced cancer

Daraxonrasib nearly doubles survival in previously treated metastatic pancreatic cancer

Yoga improves mood, fatigue, and insomnia in cancer survivors following treatment

Lorlatinib delivers 7-year progression-free survival and durable brain control in ALK+ NSCLC

Apalutamide plus ADT improves surgical outcomes in high-risk prostate cancer

Abemaciclib shows benefit in dedifferentiated liposarcoma

Adjuvant selpercatinib reduces recurrence in RET-positive lung cancer

Low-dose pembrolizumab plus chemotherapy improves survival and expands access in advanced NSCLC

ASCO 2026: Latest updates in mRCC

Adagloxad simolenin plus OBI-821 shows no survival benefit compared to standard of care in triple-negative breast cancer